GleamWall
中文EN

INGN Inogen Inc

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1294133 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.7%
TTM net income YoY-39.7%
TTM EPS YoY-32.0%
Revenue 3-yr CAGR5.0%
Net income 3-yr CAGR—

Margins

Gross margin39.6%
Operating margin-10.4%
Net margin-9.3%
FCF margin-3.0%
EBITDA margin-4.2%

Returns

ROE-20.0%
ROA-12.4%
ROIC (approx.)-37.5%
Asset turnover1.33x

Leverage & solvency

Liabilities / assets40.7%
Debt / equity0.00x
Current ratio2.96x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.26x
Accruals ratio-9.2%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$77.19M$95.08M$85.11M$121.94M$79.09M$92.28M$82.28M$80.08M
Cost of revenue$43.19M$51.81M$47.25M$69.93M$42.92M$50.94M$45.91M$43.79M
Gross profit$34.01M$43.27M$37.86M$35.24M$36.16M$41.34M$36.37M$36.29M
R&D expense$5.40M$5.87M$5.10M$5.32M$4.84M$5.21M$4.03M$5.90M
SG&A expense$14.74M$17.67M$17.50M$16.12M$16.13M$16.87M$16.24M$17.62M
Operating income-$15.58M-$5.10M-$9.34M-$9.31M-$5.43M-$6.13M-$7.66M-$11.39M
Pretax income-$14.64M-$4.00M-$8.50M-$9.81M-$3.76M-$4.30M-$6.27M-$10.09M
Income tax$153,000-$154,000-$174,000-$236,000-$146,000-$153,000-$97,000-$330,000
Net income-$16.16M-$3.85M-$8.32M-$7.13M-$5.29M-$4.15M-$6.17M-$9.76M
EBITDA-$14.71M-$1.65M-$4.43M$4.74M-$4.46M-$2.12M-$2.47M-$6.31M
EPS (basic)-0.61-0.14-0.30—-0.20-0.15-0.25—
EPS (diluted)-0.61-0.14-0.30—-0.20-0.15-0.25—
Weighted avg. shares (diluted)26.46M27.05M27.32M—27.08M26.96M25.16M—
Balance sheet
Cash & equivalents$81.84M$87.28M$93.11M$103.73M$106.48M$103.69M$118.89M$113.80M
Short-term investments$15.00M$18.26M$17.06M$15.85M$16.75M$18.75M—$0
Receivables$48.61M$46.16M$41.87M$34.14M$40.37M$38.59M$36.62M$29.56M
Inventory$29.04M$28.63M$24.99M$25.97M$25.07M$24.31M$26.27M$24.81M
Current assets$208.32M$194.14M$190.66M$224.60M$203.72M$203.12M$200.71M$185.45M
PP&E, net$8.62M$31.78M$33.69M$10.06M$37.33M$40.17M$41.10M$44.40M
Goodwill$0$10.39M$10.48M$10.70M$10.70M$10.70M$9.86M$9.46M
Intangibles$26.08M$27.45M$28.91M$30.76M$32.05M$33.36M$31.61M$30.49M
Total assets$264.91M$285.57M$285.93M$298.62M$307.01M$312.04M$308.41M$296.19M
Current liabilities$70.27M$70.86M$61.45M$63.53M$64.94M$67.07M$65.45M$76.69M
Total liabilities$107.92M$110.71M$103.02M$106.39M$109.83M$112.55M$110.46M$122.33M
Shareholders' equity$156.99M$174.86M$182.91M$192.23M$197.18M$199.49M$197.95M$173.86M
Shares outstanding26.20M26.73M27.37M27.23M27.15M27.04M26.89M23.90M
Cash flow statement
Operating cash flow-$4.47M$2.95M-$6.68M-$943,000$2.17M$4.35M-$16.79M-$3.02M
Capital expenditure$280,000$711,000$210,000$979,000$568,000$684,000$292,000$329,000
Free cash flow-$4.75M$2.23M-$6.89M-$1.92M$1.60M$3.67M-$17.08M-$3.35M
Investing cash flow$2.19M-$3.13M-$1.98M-$1.52M-$82,000-$22.57M-$2.04M$11.54M
Financing cash flow-$3.44M-$5.62M-$2.12M-$187,000$418,000$0$23.95M-$260,000
Depreciation & amortization$876,000$3.44M$4.90M$14.05M$970,000$4.01M$5.19M$5.08M
Stock-based compensation$1.76M$1.77M$1.95M$1.81M$1.74M$2.29M$2.15M$1.69M
Share buybacks$3.75M$5.62M$1.87M—————

Free plan shows the latest 8 periods; Pro shows all 55 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.